LGND Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $34,236,028.79

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$316.66

▲ +0.526 (0.17%)

As of 11/5/2026 10:13 AM ET

Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/2/2026	Andrew Reardon	Insider	Sell	5,000	$313.22	$1,566,100.00	31,854
11/2/2026	Jason Aryeh	Director	Sell	700	$320.43	$224,301.00	108,758
10/30/2026	Jason Aryeh	Director	Sell	1,411	$320.24	$451,858.64	109,458
10/2/2026	Andrew Reardon	Insider	Sell	5,000	$304.07	$1,520,350.00	31,854
9/10/2026	Martine Zimmermann	Director	Sell	1,200	$285.00	$342,000.00	3,897
9/3/2026	Andrew Reardon	Insider	Sell	5,000	$286.09	$1,430,450.00	36,514
8/12/2026	Jason Haas	Director	Sell	7,138	$292.81	$2,090,077.78	3,981
8/12/2026	Octavio Espinoza	CFO	Sell	31,641	$292.06	$9,241,070.46	27,696
8/3/2026	Andrew Reardon	Insider	Sell	5,000	$288.99	$1,444,950.00	41,514
7/1/2026	Andrew Reardon	Insider	Sell	5,000	$313.28	$1,566,400.00	41,514
6/16/2026	Stephen L. Sabba	Director	Sell	2,145	$254.00	$544,830.00	33,629
6/12/2026	Jason Haas	Director	Sell	6,461	$255.58	$1,651,302.38	4,981
6/11/2026	Jason Aryeh	Director	Sell	4,500	$250.00	$1,125,000.00	102,580
6/10/2026	Jason Aryeh	Director	Sell	500	$250.00	$125,000.00	107,080
6/10/2026	John L. LaMattina	Director	Sell	4,591	$250.88	$1,151,790.08	26,969
6/1/2026	Andrew Reardon	Insider	Sell	5,000	$227.06	$1,135,300.00	41,382
5/13/2026	John W. Kozarich	Director	Sell	1,575	$223.50	$352,012.50	41,786
5/12/2026	John W. Kozarich	Director	Sell	459	$224.00	$102,816.00	41,786
5/1/2026	Andrew Reardon	Insider	Sell	5,000	$231.31	$1,156,550.00	41,382
5/1/2026	John W. Kozarich	Director	Sell	467	$231.80	$108,250.60	41,786
4/1/2026	Andrew Reardon	Insider	Sell	5,000	$201.24	$1,006,200.00	41,382
4/1/2026	John W. Kozarich	Director	Sell	467	$202.23	$94,441.41	42,253
3/23/2026	Stephen L. Sabba	Director	Sell	1,000	$207.87	$207,870.00	32,793
3/11/2026	Octavio Espinoza	CFO	Sell	3,057	$225.00	$687,825.00	21,010
3/4/2026	Andrew Reardon	Insider	Sell	5,000	$206.35	$1,031,750.00	36,869
3/4/2026	Octavio Espinoza	CFO	Sell	13,423	$205.83	$2,762,856.09	21,662
3/3/2026	Stephen L. Sabba	Director	Sell	2,034	$201.50	$409,851.00	33,793
3/2/2026	John W. Kozarich	Director	Sell	467	$200.50	$93,633.50	42,720
2/2/2026	John W. Kozarich	Director	Sell	467	$195.91	$91,489.97	43,187
1/2/2026	John W. Kozarich	Director	Sell	467	$189.58	$88,533.86	43,654
12/12/2025	Octavio Espinoza	CFO	Sell	1,804	$188.31	$339,711.24	26,186
12/1/2025	John W. Kozarich	Director	Sell	467	$195.84	$91,457.28	44,121
11/3/2025	John W. Kozarich	Director	Sell	467	$191.05	$89,220.35	44,588
10/1/2025	John W. Kozarich	Director	Sell	467	$179.44	$83,798.48	45,055
9/23/2025	Jason Aryeh	Director	Sell	10,000	$170.81	$1,708,100.00	69,289
9/2/2025	John W. Kozarich	Director	Sell	467	$162.26	$75,775.42	45,522
8/1/2025	John W. Kozarich	Director	Sell	467	$131.88	$61,587.96	45,989
7/10/2025	John W. Kozarich	Director	Sell	934	$125.00	$116,750.00	46,456
6/23/2025	Andrew Reardon	Insider	Sell	500	$114.08	$57,040.00	31,903
6/10/2025	Andrew Reardon	Insider	Sell	500	$114.54	$57,270.00	32,403
5/15/2025	Andrew Reardon	Insider	Sell	1,000	$104.00	$104,000.00	32,903
5/9/2025	Octavio Espinoza	CFO	Buy	1,500	$104.06	$156,090.00	27,932
5/9/2025	Todd C. Davis	CEO	Buy	9,510	$105.20	$1,000,452.00	161,234
3/4/2025	Octavio Espinoza	CFO	Sell	5,000	$115.03	$575,150.00	18,879
12/23/2024	Octavio Espinoza	CFO	Sell	2,104	$116.37	$244,842.48	20,647
11/27/2024	John L. LaMattina	Director	Sell	2,406	$123.65	$297,501.90	29,515
9/23/2024	Andrew Reardon	Insider	Sell	2,000	$99.60	$199,200.00	22,534
9/23/2024	Matthew E Korenberg	COO	Sell	9,772	$101.22	$989,121.84	50,777
9/20/2024	Matthew E Korenberg	COO	Sell	6,275	$104.10	$653,227.50	50,777
9/20/2024	Octavio Espinoza	CFO	Sell	1,275	$103.94	$132,523.50	24,610
8/28/2024	Andrew Reardon	Insider	Sell	1,500	$106.39	$159,585.00	22,534
8/26/2024	Matthew E Korenberg	COO	Sell	11,389	$105.61	$1,202,792.29	49,510
8/22/2024	Matthew E Korenberg	COO	Sell	1,157	$105.54	$122,109.78	67,211
8/9/2024	Matthew E Korenberg	COO	Sell	18,245	$98.50	$1,797,132.50	68,368
8/8/2024	Todd C. Davis	CEO	Buy	2,500	$97.39	$243,475.00	123,010
5/17/2024	Octavio Espinoza	CFO	Sell	5,156	$86.66	$446,818.96	23,379
5/15/2024	Octavio Espinoza	CFO	Sell	5,873	$86.01	$505,136.73	23,882
5/13/2024	Matthew E Korenberg	Insider	Sell	3,440	$84.54	$290,817.60	100,421
5/9/2024	Andrew Reardon	Insider	Sell	10,000	$83.04	$830,400.00	22,205
5/9/2024	Nancy Ryan Gray	Director	Sell	934	$83.20	$77,708.80	5,633
3/5/2024	Stephen L. Sabba	Director	Sell	1,893	$74.30	$140,649.90	28,926
2/28/2024	Octavio Espinoza	CFO	Sell	140	$88.46	$12,384.40	29,755

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/5/2026	Lido Advisors LLC	2,809	$0.88M	0.0%	+11.6%	0.014%
11/5/2026	Keybank National Association OH	888	$0.28M	0.0%	-56.7%	0.004%
11/4/2026	Penn Capital Management Company LLC	98,747	$30.88M	2.2%	-1.6%	0.494%
11/4/2026	Villere ST Denis J & Co. LLC	93,325	$29.15M	3.0%	-40.0%	0.467%
11/4/2026	Allspring Global Investments Holdings LLC	52,094	$15.77M	0.0%	+0.3%	0.260%
11/3/2026	Ethic Inc.	1,002	$0.31M	0.0%	+7.4%	0.005%
11/3/2026	Alps Advisors Inc.	2,063	$0.64M	0.0%	-16.6%	0.010%
11/3/2026	Waldron Private Wealth LLC	780	$0.24M	0.0%	N/A	0.004%
11/2/2026	Commonwealth Equity Services LLC	1,784	$0.56M	0.0%	+5.3%	0.009%
10/31/2026	Covestor Ltd	337	$0.11M	0.1%	+49.8%	0.002%
10/30/2026	Oregon Public Employees Retirement Fund	4,473	$1.40M	0.0%	-2.3%	0.022%
10/30/2026	XML Financial LLC	721	$0.23M	0.0%	N/A	0.004%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	1,019	$0.32M	0.0%	N/A	0.005%
10/29/2026	Profund Advisors LLC	6,253	$1.95M	0.1%	+191.0%	0.031%
10/29/2026	ProShare Advisors LLC	3,444	$1.08M	0.0%	-2.2%	0.017%
10/29/2026	Vise Technologies Inc.	654	$0.20M	0.0%	-45.8%	0.003%
10/28/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	7,100	$2.22M	0.0%	+65.1%	0.036%
10/28/2026	Choreo LLC	1,634	$0.51M	0.0%	+3.0%	0.008%
10/28/2026	China Universal Asset Management Co. Ltd.	3,637	$1.13M	0.1%	+14.0%	0.000%
10/27/2026	Moody Aldrich Partners LLC	18,952	$5.92M	1.1%	-32.7%	0.095%
10/23/2026	Sowell Financial Services LLC	1,652	$0.52M	0.0%	+6.8%	0.008%
10/23/2026	Evergreen Capital Management LLC	2,230	$0.70M	0.0%	-2.2%	0.011%
10/23/2026	Gibbs Wealth Management	7,713	$2.41M	0.2%	+6.7%	0.039%
10/23/2026	Wedbush Securities Inc.	954	$0.30M	0.0%	-11.7%	0.005%
10/22/2026	Yousif Capital Management LLC	5,394	$1.69M	0.0%	-1.0%	0.027%
10/22/2026	Isthmus Partners LLC	16,326	$5.10M	0.5%	-22.0%	0.082%
10/21/2026	Kings Path Partners LLC	3,960	$1.24M	0.3%	N/A	0.020%
10/21/2026	Crossmark Global Holdings Inc.	2,416	$0.76M	0.0%	+12.5%	0.012%
10/21/2026	Sowell Financial Services LLC	1,652	$0.52M	0.0%	+6.8%	0.008%
10/21/2026	Nisa Investment Advisors LLC	787	$0.25M	0.0%	-23.6%	0.004%
10/21/2026	Diversify Advisory Services LLC	9,410	$2.81M	0.0%	+18.3%	0.047%
10/15/2026	State of Alaska Department of Revenue	5,921	$1.85M	0.0%	-42.1%	0.030%
10/14/2026	Thurston Springer Miller Herd & Titak Inc.	79	$25K	0.0%	-66.5%	0.000%
10/14/2026	B. Riley Wealth Advisors Inc.	2,465	$0.77M	0.0%	N/A	0.012%
10/13/2026	Contravisory Investment Management Inc.	2,148	$0.67M	0.1%	+4.9%	0.011%
10/13/2026	Woodstock Corp	18,245	$5.70M	0.5%	-0.5%	0.092%
10/9/2026	GK Wealth Management LLC	389	$0.12M	0.1%	N/A	0.002%
10/9/2026	GAMMA Investing LLC	813	$0.25M	0.0%	+19.4%	0.004%
10/8/2026	Farther Finance Advisors LLC	173	$54K	0.0%	-21.0%	0.001%
10/8/2026	CoreCap Advisors LLC	603	$0.19M	0.0%	+40.9%	0.003%
10/6/2026	Congress Asset Management Co.	658,556	$205.71M	1.3%	-0.2%	3.303%
10/6/2026	Moody National Bank Trust Division	13,862	$4.33M	0.3%	+14.1%	0.070%
10/5/2026	Argent Capital Management LLC	3,539	$1.11M	0.0%	-6.9%	0.018%
9/29/2026	Cim Investment Management Inc.	1,606	$0.51M	0.1%	+8.2%	0.008%
9/23/2026	Envestnet Portfolio Solutions Inc.	1,039	$0.33M	0.0%	N/A	0.005%
9/9/2026	Sequoia Financial Advisors LLC	1,169	$0.37M	0.0%	-2.9%	0.006%
9/9/2026	MCF Advisors LLC	243	$77K	0.0%	+118.9%	0.001%
9/9/2026	Integrated Wealth Concepts LLC	85	$27K	0.0%	N/A	0.000%
9/9/2026	Squarepoint Ops LLC	22,800	$7.21M	0.0%	+256.6%	0.114%
9/9/2026	Baird Financial Group Inc.	8,550	$2.70M	0.0%	-34.1%	0.043%
9/8/2026	JW Asset Management LLC	4,000	$1.26M	0.4%	N/A	0.020%
9/8/2026	Arizona State Retirement System	5,365	$1.70M	0.0%	-0.8%	0.027%
9/8/2026	Waverly Advisors LLC	870	$0.28M	0.0%	N/A	0.004%
9/8/2026	Nykredit A S	864	$0.27M	0.0%	N/A	0.004%
9/2/2026	Allianz Asset Management GmbH	2,400	$0.76M	0.0%	N/A	0.012%
8/27/2026	Corient Private Wealth LP	11,692	$3.70M	0.0%	+84.1%	0.059%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	4,300	$1.36M	0.0%	N/A	0.022%
8/22/2026	TD Waterhouse Canada Inc.	19,625	$6.12M	0.0%	N/A	0.098%
8/21/2026	Nykredit A S	864	$0.27M	0.0%	N/A	0.004%
8/20/2026	BTG Pactual Asset Management US LLC	1,123	$0.36M	0.0%	+7.1%	0.006%
8/19/2026	Wellington Management Group LLP	7,197	$2.28M	0.0%	-9.0%	0.036%
8/13/2026	Ranger Investment Management L.P.	257,596	$81.42M	5.2%	N/A	1.292%
8/6/2026	Bank of New York Mellon Corp	131,068	$41.43M	0.0%	N/A	0.654%
7/10/2026	Handelsbanken Fonder AB	10,358	$3.27M	0.0%	+22.5%	0.052%
7/8/2026	Thurston Springer Miller Herd & Titak Inc.	236	$75K	0.0%	N/A	0.001%
7/7/2026	Balefire LLC	1,043	$0.33M	0.1%	N/A	0.005%
7/7/2026	GAMMA Investing LLC	681	$0.22M	0.0%	+5.7%	0.003%
7/7/2026	Moody National Bank Trust Division	12,147	$3.84M	0.3%	N/A	0.061%
7/7/2026	CoreCap Advisors LLC	428	$0.14M	0.0%	+14,166.7%	0.002%
7/7/2026	City Center Advisors LLC	1,266	$0.40M	0.3%	-29.5%	0.006%
6/18/2026	Pacer Advisors Inc.	1,317	$0.26M	0.0%	N/A	0.007%
5/26/2026	Glenmede Trust Co. NA	4,050	$0.81M	0.0%	-9.6%	0.020%
5/22/2026	Segall Bryant & Hamill LLC	6,045	$1.34M	0.0%	N/A	0.030%
5/21/2026	Argent Capital Management LLC	3,485	$0.70M	0.0%	N/A	0.017%
5/19/2026	Cim Investment Management Inc.	1,484	$0.30M	0.1%	+3.4%	0.007%
5/19/2026	Bank of America Corp DE	157,865	$31.52M	0.0%	+31.4%	0.788%
5/19/2026	Edgestream Partners L.P.	11,584	$2.31M	0.1%	-49.4%	0.058%
5/19/2026	Janus Henderson Group PLC	1,009,891	$201.62M	0.1%	+1.5%	5.039%
5/18/2026	Amundi	3,555	$0.71M	0.0%	+17.2%	0.018%
5/18/2026	California State Teachers Retirement System	23,784	$4.75M	0.0%	+26.5%	0.119%
5/18/2026	Royal Bank of Canada	111,543	$22.27M	0.0%	+2.5%	0.557%
5/18/2026	Ranger Investment Management L.P.	267,943	$53.50M	3.9%	-0.8%	1.337%
5/18/2026	Empowered Funds LLC	2,540	$0.51M	0.0%	N/A	0.013%
5/16/2026	Ashford Capital Management Inc.	207,565	$41.44M	5.1%	-2.9%	1.036%
5/16/2026	The Manufacturers Life Insurance Company	8,909	$1.78M	0.0%	-2.2%	0.044%
5/16/2026	Quantinno Capital Management LP	6,227	$1.24M	0.0%	+107.6%	0.031%
5/16/2026	Castleark Management LLC	48,696	$9.72M	0.3%	-27.0%	0.243%
5/15/2026	Rice Hall James & Associates LLC	283,567	$56.61M	3.1%	+1.4%	1.415%
5/15/2026	Granahan Investment Management LLC	24,165	$4.83M	0.2%	-7.2%	0.121%
5/14/2026	Public Employees Retirement System of Ohio	2,685	$0.54M	0.0%	-67.6%	0.013%
5/14/2026	Arrowstreet Capital Limited Partnership	14,564	$2.91M	0.0%	-27.3%	0.073%
5/14/2026	Caxton Associates LLP	18,651	$3.72M	0.1%	+28.6%	0.093%
5/14/2026	Gibbs Wealth Management	5,563	$1.11M	0.1%	+66.2%	0.028%
5/14/2026	Sei Investments Co.	75,188	$15.01M	0.0%	+62.2%	0.375%
5/14/2026	Group One Trading LLC	1,669	$0.33M	0.0%	-43.5%	0.008%
5/14/2026	Lido Advisors LLC	2,757	$0.55M	0.0%	+23.5%	0.014%
5/14/2026	Walleye Capital LLC	10,333	$2.06M	0.0%	N/A	0.052%
5/13/2026	Cetera Investment Advisers	4,259	$0.85M	0.0%	+27.7%	0.021%
5/13/2026	First Trust Advisors LP	80,401	$16.05M	0.0%	+16.2%	0.401%
5/8/2026	PNC Financial Services Group Inc.	2,342	$0.47M	0.0%	+4.6%	0.012%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.

Today's Range

Now: $316.66

$310.09

$316.65

50 Day Range

MA: $298.16

$275.20

$322.75

52 Week Range

Now: $316.66

$175.89

$326.63

Volume

6,600 shs

Average Volume

266,137 shs

Market Capitalization

$6.33 billion

P/E Ratio

141.46

Dividend Yield

N/A

Beta

1.16

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
John L Higgins (Director)
John L Higgins (CEO)
Matthew W Foehr (COO)
Todd C Davis (CEO)
John Higgins (CEO)
Matthew W Foehr (Insider)
Jason Aryeh (Director)
Matthew E Korenberg (Insider)
Matthew E Korenberg (COO)
Todd C Davis (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
Congress Asset Management Co. — 3.30%
Penn Capital Management Company LLC — 0.49%
Villere ST Denis J & Co. LLC — 0.47%
Allspring Global Investments Holdings LLC — 0.26%
Moody Aldrich Partners LLC — 0.10%
Woodstock Corp — 0.09%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are selling Ligand Pharmaceuticals stock?: In the previous quarter, LGND stock was sold by these institutional investors:
Villere ST Denis J & Co. LLC
Moody Aldrich Partners LLC
Isthmus Partners LLC
State of Alaska Department of Revenue
Penn Capital Management Company LLC
Congress Asset Management Co.
Keybank National Association OH
Vise Technologies Inc.
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
Jason Aryeh (Director)
John W Kozarich (Director)
Andrew Reardon (Insider)
Stephen L Sabba (Director)
Octavio Espinoza (CFO)
John L Lamattina (Director)
Jason Haas (Director)
Martine Zimmermann (Director)
Learn More investors selling Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: During the previous quarter, LGND stock was acquired by institutional investors including:
Profund Advisors LLC
Kings Path Partners LLC
VIRGINIA RETIREMENT SYSTEMS ET Al
B. Riley Wealth Advisors Inc.
Moody National Bank Trust Division
Diversify Advisory Services LLC
Mirae Asset Global Investments Co. Ltd.
Waldron Private Wealth LLC
Within the last year, these company insiders have bought Ligand Pharmaceuticals stock:
Todd C Davis (CEO)
Octavio Espinoza (CFO)
Learn More investors buying Ligand Pharmaceuticals stock.